Consensus Beximco Pharmaceuticals Limited

Equities

BXPHARMA

BD0453BXPH04

End-of-day quote Dhaka S.E. Other stock markets 06:00:00 2024-04-17 pm EDT			5-day change	1st Jan Change
117.7 ^BDT	-1.51%		-1.59%	-19.49%

Mar. 04	Beximco names Iqbal Ahmed as managing director	AN
Jan. 30	Beximco Pharmaceuticals to strengthen portfolio as interim profit up	AN

Evolution of the average Target Price on Beximco Pharmaceuticals Limited

Price target over the last 5 years

History of analyst recommendation changes

5fbc31b9f3e416475efe7f4efa.uVFUONjjes9Y7QiMfvXBjXUOlDJTJms9vavEtpatzBY.9wMnXombFKgS1ErfMrOOtUZ390IRRx1O0cGc-tzC_HXvKQ0M9aE-oiGkQQ~a62c546121020e6ae3645b2380f18316

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

117.7 BDT

Average target price

153.5 BDT

Spread / Average Target

+30.42%

High Price Target

157 BDT

Spread / Highest target

+33.39%

Low Price Target

150 BDT

Spread / Lowest Target

+27.44%

Consensus detail

Consensus revision (last 18 months)

Ratings for Beximco Pharmaceuticals Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar